Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03827720 · ClinicalTrials.gov registry record · NA
Early Feasibility Study of the SENSE Device
A NA study, sponsored by Sense Diagnostics.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT03827720 is a NA study that has completed, run by Sense Diagnostics. The registered enrollment target is 20 participants.
The verdict
NCT03827720, a NA study, has completed, sponsored by Sense Diagnostics.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
A single site, study of the SENSE device in up to 20 study subjects, (five healthy controls and five each with ICH, AIS with LVO and AIS without LVO) in whom SENSE can be applied within 24 hours of stroke symptom onset.
Interventions
- DEVICE SENSE Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2019-06-06 |
| Est. Completion | 2021-01-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03827720
The ClinicalTrials.gov registry entry for NCT03827720 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sense Diagnostics, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SENSE Device is the first listed.
NCT03827720 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03827720 about?
NCT03827720 is a clinical study titled "Early Feasibility Study of the SENSE Device". A single site, study of the SENSE device in up to 20 study subjects, (five healthy controls and five each with ICH, AIS with LVO and AIS without LVO) in whom SENSE can be applied within 24 hours of stroke symptom onset.
What is the current status of trial NCT03827720?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2019-06-06. Estimated completion is 2021-01-04.
What interventions are being tested in trial NCT03827720?
The interventions under investigation include: SENSE Device (DEVICE).
Who is sponsoring clinical trial NCT03827720?
This trial is sponsored by Sense Diagnostics, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.